Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University, 1230 York Avenue, New York, NY, USA.
Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 753/5, 625 00, Brno, Czech Republic.
Eur Spine J. 2019 Apr;28(4):783-791. doi: 10.1007/s00586-018-5838-z. Epub 2018 Dec 1.
The presence of Propionibacterium acnes in a substantial component of resected disc specimens obtained from patients undergoing discectomy or microdiscectomy has led to the suggestion that this prominent human skin and oral commensal may exacerbate the pathology of degenerative disc disease. This hypothesis, therefore, raises the exciting possibility that antibiotics could play an important role in treating this debilitating condition. To date, however, little information about antibiotic penetration into the intervertebral disc is available.
Intervertebral disc tissue obtained from 54 microdiscectomy patients given prophylactic cefazolin (n = 25), clindamycin (n = 17) or vancomycin (n = 12) was assayed by high-performance liquid chromatography, with cefaclor as an internal standard, to determine the concentration of antibiotic penetrating into the disc tissue.
Intervertebral disc tissues from patients receiving the positively charged antibiotic clindamycin contained a significantly greater percentage of the antibacterial dose than the tissue from patients receiving negatively charged cefazolin (P < 0.0001) and vancomycin, which has a slight positive charge (P < 0.0001).
Positively charged antibiotics appear more appropriate for future studies investigating potential options for the treatment of low-virulence disc infections. These slides can be retrieved under Electronic Supplementary Material.
从接受椎间盘切除术或微创手术的患者切除的椎间盘标本中发现大量痤疮丙酸杆菌的存在,这表明这种常见的皮肤和口腔共生菌可能会加剧退行性椎间盘疾病的病理。因此,这一假设提出了一个令人兴奋的可能性,即抗生素可能在治疗这种使人衰弱的疾病中发挥重要作用。然而,到目前为止,关于抗生素渗透到椎间盘内的信息很少。
对 54 例接受预防性头孢唑啉(n=25)、克林霉素(n=17)或万古霉素(n=12)治疗的微创手术患者的椎间盘组织进行了高效液相色谱分析,以头孢克洛为内标,测定抗生素穿透椎间盘组织的浓度。
接受带正电荷的抗生素克林霉素治疗的患者的椎间盘组织中,抗菌剂量的百分比明显高于接受带负电荷的头孢唑啉(P<0.0001)和带轻微正电荷的万古霉素(P<0.0001)治疗的患者。
带正电荷的抗生素似乎更适合未来研究治疗低毒力椎间盘感染的潜在选择。这些幻灯片可以在电子补充材料中检索到。